Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 12;294(35):13027–13039. doi: 10.1074/jbc.RA118.006865

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 McDermott et al.

Author's Choice—Final version open access under the terms of the Creative Commons CC-BY license.

PMC Copyright notice

Figure 3. — Cytokine secretion levels following exposure to IL-1β. A, CCL2 levels in SW1353 medium following 24-h exposure to IL-1β at concentrations ranging from 0 to 10 ng/ml. B, CCL2 levels in HAC (M70, M76, and M86) medium following 24-h exposure to IL-1β at concentrations ranging from 0 to 10 ng/ml. C, CCL2 levels in SW1353 medium following 10 ng/ml IL-1β treatment for 0–48 h. D, CCL2 levels in HAC (M69, F80, and F86) medium following 10 ng/ml IL-1β treatment for 0–48 h. E, IL-6 levels in SW1353 medium following 24-h exposure to IL-1β at concentrations ranging from 0 to 10 ng/ml. F, IL-6 levels in HAC (M70, M76, and M86) medium following 24-h exposure to IL-1β at concentrations ranging from 0 to 10 ng/ml. G, IL-6 levels in SW1353 medium following 10 ng/ml IL-1β treatment for 0–48 h. H, IL-6 levels in HAC (M69, F80, and F86) medium following 10 ng/ml IL-1β treatment for 0–48 h. Data were considered significant if p = <0.05 (*) and p = <0.01 (**) following Dunnett's multiple comparison tests.